Mecobion-NP Tablet SR is a sustained-release formulation combining Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, designed for the management of neuropathic pain and associated neurological conditions. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, modulates calcium channel function to reduce neurotransmitter release, thereby alleviating neuropathic pain and improving nerve function. Nortriptyline, a tricyclic antidepressant, exerts analgesic effects through inhibition of norepinephrine and serotonin reuptake, enhancing descending inhibitory pain pathways and providing mood stabilization. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by promoting myelin sheath synthesis and neuronal metabolism. The sustained-release formulation ensures prolonged therapeutic plasma levels, improving patient compliance and minimizing dosing frequency. Mecobion-NP is indicated for diabetic neuropathy, postherpetic neuralgia, peripheral neuropathies, and other chronic neuropathic pain syndromes. It is essential to administer this medication under medical supervision, considering potential side effects such as dizziness, dry mouth, sedation, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiac conditions, or a history of seizures. Regular monitoring and dose adjustments may be necessary to optimize therapeutic outcomes while minimizing adverse effects. Mecobion-NP Tablet SR offers a multimodal approach for effective neuropathic pain management and nerve health restoration.